July 27, 2021
TORONTO, ONTARIO, July 27, 2021 – Rapid Dose Therapeutics Corp. (the “Company”) (CSE: DOSE) is providing a bi-weekly update on the status of the management cease trade order granted on June 29, 2021 (the “MCTO”) by its principal regulator, the Ontario Securities Commission, in accordance...
July 22, 2021
Rapid Dose Therapeutics Announces the Appointment of Advisory Board Ron Brooks, CPA, CA, ICD.D, Nick DiRenzo, FCA, FCPA, ICD.D and Anne Lachance, ICD.D appointed to help support the Company’s global expansion BURLINGTON, Ontario – July 22, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”)...
July 20, 2021
Rapid Dose Therapeutics and McMaster University Enter Next Stage of COVID-19 QuickStrip™ Vaccine Research Ahead of Schedule Pre-clinical in vivo testing expected to prove efficacy of QuickStrip technology in the delivery of vaccines BURLINGTON, Ontario – July 20, 2021- Rapid Dose Therapeutics Corp. (“RDT”...
July 14, 2021
Rapid Dose Provides Bi-Weekly Status Report Regarding Management Cease Trade Order and Update Regarding Interim Financial Statements TORONTO, ONTARIO, July 13, 2021 – Rapid Dose Therapeutics Corp. (the “Company”) (CSE: DOSE) is providing a bi-weekly update on the status of the management cease trade order...
July 13, 2021
Rapid Dose Therapeutics-Branded Cannabis Products in Retail Locations Across Canada Via Master Distribution Agreement with Namaste Technologies Subsidiary CannMart Rapid Dose Therapeutics Announces its Latest Innovation with the Launch of QuickSips™ Biodegradable Infused Straw BURLINGTON, Ontario – July 13, 2021- Rapid Dose Therapeutics Corp. (“RDT”...
June 29, 2021
Rapid Dose Granted Management Cease Trade Order TORONTO, ONTARIO, June 29, 2021 – Rapid Dose Therapeutics Corp. (the “Company”) (CSE: DOSE) announces that, further to its news release dated June 18, 2021, the Company’s principal regulator, the Ontario Securities Commission (the “OSC”) granted a management...
June 23, 2021
The National Research Council of Canada provides the SARS-CoV-2 spike protein for the next phase of preclinical studies BURLINGTON, Ontario – June 23, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) and McMaster University (“McMaster”) are pleased to announce that they have...
April 13, 2021
BURLINGTON, Ontario – April 13, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian Life Science company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film, infused with an active...
March 19, 2021
BURLINGTON, Ontario, March 19, 2021 (GLOBE NEWSWIRE) — Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film infused with an...
March 10, 2021
BURLINGTON, Ontario, March 10, 2021 (GLOBE NEWSWIRE) — Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is a Canadian Life Science company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film, infused with an active...